IP Library Granted Patent US 8,187,632
Granted Patent B2
US 8,187,632 · App. 11/762,831 · Granted May 29, 2012

Sustained-release preparations of quinolone antibiotics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,187,632
App. No.
11/762,831
Granted
May 29, 2012
Kind
B2
Abstract

The present invention relates to an orally administrable preparation comprising a quinolone antibiotic which releases the active compound with a delay.

Claims (9)

1. An orally administrable antibiotic matrix preparation comprising a quinolone active compound, wherein the preparation comprises a rapid-release part containing a quinolone active compound and a disintegrant, and a delayed-release part containing a mixture of a salt with the free base of the quinolone active compound at a salt-to-free base weight ratio of from about 1:10 to about 10:1 and an organic acid having from 2 to 10 carbon atoms and from 1 to 4 carboxyl groups.

2. The preparation of claim 1 , wherein the salt and free base are ciprofloxacin hydrochloride and ciprofloxacin betaine, respectively.

3. The preparation of claim 1 , wherein the rapid-release part contains ciprofloxacin hydrochloride, ciprofloxacin betaine, or a mixture thereof.

4. The preparation of claim 1 , wherein the disintegrant is crosslinked polyvinyl pyrrolidone.

5. The preparation of claim 1 , wherein the organic acid is selected from the group consisting of acetic acid, malonic acid, succinic acid, fumaric acid, tartaric acid and citric acid.

6. The preparation of claim 1 , wherein the organic acid is succinic acid.

7. The preparation of claim 1 , wherein the delayed-release part further comprises a gel-forming polymer selected from the group consisting of alkylcellulose, hydroxyalkylcellulose, and carboxyalkylcellulose and its alkali metal salts.

8. The preparation of claim 7 , wherein the gel-forming polymer is a hydroxyalkylcellulose.

9. The preparation of claim 7 , wherein the gel-forming polymer is a crosslinked carboxymethylcellulose or an alkali metal salt thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2013
From: BAYER PHARMA AG
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029839/0959 →
CHANGE OF NAME Recorded Oct 18, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AG
Reel/Frame 029150/0303 →
MERGER Recorded Feb 19, 2009
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AG
Reel/Frame 022277/0324 →